0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Traveler's Diarrhea Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-11I13103
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Traveler s Diarrhea Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Traveler's Diarrhea Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-11I13103
Report
July 2025
Pages:134
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Traveler's Diarrhea Therapeutics Market Size

In 2024, the global market size of Traveler's Diarrhea Therapeutics was estimated to be worth US$ 900 million and is forecast to reach approximately US$ 1445 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.

Traveler's Diarrhea Therapeutics Market

Traveler's Diarrhea Therapeutics Market

Traveler"s diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
North America is the largest Traveler"s Diarrhea Therapeutics market with about 45% market share. Europe is follower, accounting for about 42% market share.The key manufacturers are Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron etc. Top 3 companies occupied about 35% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Traveler's Diarrhea Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Traveler's Diarrhea Therapeutics.
The Traveler's Diarrhea Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Traveler's Diarrhea Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Traveler's Diarrhea Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Traveler's Diarrhea Therapeutics Market Report

Report Metric Details
Report Name Traveler's Diarrhea Therapeutics Market
CAGR 7.1%
Segment by Type
Segment by Application
  • Adult Traveler's Diarrhea
  • Children Traveler's Diarrhea
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Traveler's Diarrhea Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Traveler's Diarrhea Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Traveler's Diarrhea Therapeutics sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Traveler's Diarrhea Therapeutics Market share by region?

Ans: North America is the largest Traveler"s Diarrhea Therapeutics market with about 45% market share. Europe is follower, accounting for about 42% market share.

What is the market share of major companies in Traveler's Diarrhea Therapeutics Market?

Ans: Top 3 companies occupied about 35% market share.

Who are the main players in the Traveler's Diarrhea Therapeutics Market report?

Ans: The main players in the Traveler's Diarrhea Therapeutics Market are Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron

What are the Application segmentation covered in the Traveler's Diarrhea Therapeutics Market report?

Ans: The Applications covered in the Traveler's Diarrhea Therapeutics Market report are Adult Traveler's Diarrhea, Children Traveler's Diarrhea

What are the Type segmentation covered in the Traveler's Diarrhea Therapeutics Market report?

Ans: The Types covered in the Traveler's Diarrhea Therapeutics Market report are Immunization, Non-antibiotic Agents, Antibiotics, Anti-Motility Agents, Others

Recommended Reports

Travel Health Solutions

Gastrointestinal Therapies

Infection & Immunity

1 Study Coverage
1.1 Traveler's Diarrhea Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Traveler's Diarrhea Therapeutics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Immunization
1.2.3 Non-antibiotic Agents
1.2.4 Antibiotics
1.2.5 Anti-Motility Agents
1.2.6 Others
1.3 Market by Application
1.3.1 Global Traveler's Diarrhea Therapeutics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Adult Traveler's Diarrhea
1.3.3 Children Traveler's Diarrhea
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Traveler's Diarrhea Therapeutics Market Size Estimates and Forecasts
2.1.1 Global Traveler's Diarrhea Therapeutics Revenue 2020-2031
2.1.2 Global Traveler's Diarrhea Therapeutics Sales 2020-2031
2.2 Traveler's Diarrhea Therapeutics Market Size by Region: 2024 Versus 2031
2.3 Traveler's Diarrhea Therapeutics Sales by Region (2020-2031)
2.3.1 Global Traveler's Diarrhea Therapeutics Sales by Region: 2020-2025
2.3.2 Global Traveler's Diarrhea Therapeutics Sales Forecast by Region (2026-2031)
2.3.3 Global Traveler's Diarrhea Therapeutics Sales Market Share by Region (2020-2031)
2.4 Traveler's Diarrhea Therapeutics Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Traveler's Diarrhea Therapeutics Revenue by Region: 2020-2025
2.4.2 Global Traveler's Diarrhea Therapeutics Revenue Forecast by Region (2026-2031)
2.4.3 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Traveler's Diarrhea Therapeutics Sales by Type (2020-2031)
3.1.1.1 Global Traveler's Diarrhea Therapeutics Sales Volume by Type (2020-2031)
3.1.1.2 Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2020-2031)
3.1.2 Global Traveler's Diarrhea Therapeutics Revenue by Type (2020-2031)
3.1.2.1 Global Traveler's Diarrhea Therapeutics Revenue by Type (2020-2031)
3.1.2.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2020-2031)
3.1.3 Traveler's Diarrhea Therapeutics Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Traveler's Diarrhea Therapeutics Sales by Application (2020-2031)
3.2.1.1 Global Traveler's Diarrhea Therapeutics Sales Volume by Application (2020-2031)
3.2.1.2 Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2020-2031)
3.2.2 Global Traveler's Diarrhea Therapeutics Revenue by Application (2020-2031)
3.2.2.1 Global Traveler's Diarrhea Therapeutics Revenue by Application (2020-2031)
3.2.2.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application (2020-2031)
3.2.3 Traveler's Diarrhea Therapeutics Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Immunization of Traveler's Diarrhea Therapeutics Revenue Market Share by Application
3.3.2 Non-antibiotic Agents of Traveler's Diarrhea Therapeutics Revenue Market Share by Application
3.3.3 Antibiotics of Traveler's Diarrhea Therapeutics Revenue Market Share by Application
3.3.4 Anti-Motility Agents of Traveler's Diarrhea Therapeutics Revenue Market Share by Application
3.3.5 Others of Traveler's Diarrhea Therapeutics Revenue Market Share by Application
4 Global Traveler's Diarrhea Therapeutics by Manufacturers
4.1 Global Top Traveler's Diarrhea Therapeutics Manufacturers by Sales (2020-2025)
4.1.1 Global Traveler's Diarrhea Therapeutics Sales by Manufacturer (2020-2025)
4.1.2 Global Traveler's Diarrhea Therapeutics Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Traveler's Diarrhea Therapeutics Manufacturers by Revenue (2020-2025)
4.2.1 Global Traveler's Diarrhea Therapeutics Revenue by Manufacturer (2020-2025)
4.2.2 Global Traveler's Diarrhea Therapeutics Revenue Share by Manufacturer (2020-2025)
4.3 Global Traveler's Diarrhea Therapeutics Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Traveler's Diarrhea Therapeutics Manufacturers Covered: Ranking by Revenue
4.4.2 Global Traveler's Diarrhea Therapeutics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Traveler's Diarrhea Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Traveler's Diarrhea Therapeutics Manufacturing Base Distribution, Product Type
4.5.1 Traveler's Diarrhea Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Traveler's Diarrhea Therapeutics Market
4.5.3 Manufacturers Traveler's Diarrhea Therapeutics Product Type and Application
4.5.4 Immunization Market Sales of Traveler's Diarrhea Therapeutics by Manufacturer
4.5.5 Non-antibiotic Agents Market Sales of Traveler's Diarrhea Therapeutics by Manufacturer
4.5.6 Antibiotics Market Sales of Traveler's Diarrhea Therapeutics by Manufacturer
4.5.7 Anti-Motility Agents Market Sales of Traveler's Diarrhea Therapeutics by Manufacturer
4.5.8 Others Market Sales of Traveler's Diarrhea Therapeutics by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Salix Pharmaceuticals
5.1.1 Salix Pharmaceuticals Company Information
5.1.2 Salix Pharmaceuticals Description, Business Overview
5.1.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Products Offered
5.1.4 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales by Product in 2024
5.1.6 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales by Application in 2024
5.1.7 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales by Geographic Area in 2024
5.1.8 Salix Pharmaceuticals Recent Developments
5.2 P&G
5.2.1 P&G Company Information
5.2.2 P&G Description, Business Overview
5.2.3 P&G Traveler's Diarrhea Therapeutics Products Offered
5.2.4 P&G Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.2.5 P&G Traveler's Diarrhea Therapeutics Sales by Product in 2024
5.2.6 P&G Traveler's Diarrhea Therapeutics Sales by Application in 2024
5.2.7 P&G Traveler's Diarrhea Therapeutics Sales by Geographic Area in 2024
5.2.8 P&G Recent Developments
5.3 Johnson & Johnson
5.3.1 Johnson & Johnson Company Information
5.3.2 Johnson & Johnson Description, Business Overview
5.3.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Products Offered
5.3.4 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales by Product in 2024
5.3.6 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales by Application in 2024
5.3.7 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales by Geographic Area in 2024
5.3.8 Johnson & Johnson Recent Developments
5.4 Otsuka Pharma
5.4.1 Otsuka Pharma Company Information
5.4.2 Otsuka Pharma Description, Business Overview
5.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Products Offered
5.4.4 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales by Product in 2024
5.4.6 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales by Application in 2024
5.4.7 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales by Geographic Area in 2024
5.4.8 Otsuka Pharma Recent Developments
5.5 Valneva
5.5.1 Valneva Company Information
5.5.2 Valneva Description, Business Overview
5.5.3 Valneva Traveler's Diarrhea Therapeutics Products Offered
5.5.4 Valneva Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Valneva Traveler's Diarrhea Therapeutics Sales by Product in 2024
5.5.6 Valneva Traveler's Diarrhea Therapeutics Sales by Application in 2024
5.5.7 Valneva Traveler's Diarrhea Therapeutics Sales by Geographic Area in 2024
5.5.8 Valneva Recent Developments
5.6 Shanghai United Cell
5.6.1 Shanghai United Cell Company Information
5.6.2 Shanghai United Cell Description, Business Overview
5.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Products Offered
5.6.4 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales by Product in 2024
5.6.6 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales by Application in 2024
5.6.7 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales by Geographic Area in 2024
5.6.8 Shanghai United Cell Recent Developments
5.7 PaxVax
5.7.1 PaxVax Company Information
5.7.2 PaxVax Description, Business Overview
5.7.3 PaxVax Traveler's Diarrhea Therapeutics Products Offered
5.7.4 PaxVax Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.7.5 PaxVax Traveler's Diarrhea Therapeutics Sales by Product in 2024
5.7.6 PaxVax Traveler's Diarrhea Therapeutics Sales by Application in 2024
5.7.7 PaxVax Traveler's Diarrhea Therapeutics Sales by Geographic Area in 2024
5.7.8 PaxVax Recent Developments
5.8 Livzon
5.8.1 Livzon Company Information
5.8.2 Livzon Description, Business Overview
5.8.3 Livzon Traveler's Diarrhea Therapeutics Products Offered
5.8.4 Livzon Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Livzon Traveler's Diarrhea Therapeutics Sales by Product in 2024
5.8.6 Livzon Traveler's Diarrhea Therapeutics Sales by Application in 2024
5.8.7 Livzon Traveler's Diarrhea Therapeutics Sales by Geographic Area in 2024
5.8.8 Livzon Recent Developments
5.9 Immuron
5.9.1 Immuron Company Information
5.9.2 Immuron Description, Business Overview
5.9.3 Immuron Traveler's Diarrhea Therapeutics Products Offered
5.9.4 Immuron Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Immuron Traveler's Diarrhea Therapeutics Sales by Product in 2024
5.9.6 Immuron Traveler's Diarrhea Therapeutics Sales by Application in 2024
5.9.7 Immuron Traveler's Diarrhea Therapeutics Sales by Geographic Area in 2024
5.9.8 Immuron Recent Developments
6 North America
6.1 North America Traveler's Diarrhea Therapeutics Market Size YoY Growth 2020-2031
6.2 North America Traveler's Diarrhea Therapeutics Market Facts & Figures by Country
6.2.1 North America Traveler's Diarrhea Therapeutics Sales by Country (2020-2031)
6.2.2 North America Traveler's Diarrhea Therapeutics Revenue by Country (2020-2031)
6.3 North America Traveler's Diarrhea Therapeutics Sales by Type (2020-2025)
6.4 North America Traveler's Diarrhea Therapeutics Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Traveler's Diarrhea Therapeutics Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Traveler's Diarrhea Therapeutics Market Facts & Figures by Region
7.2.1 Asia-Pacific Traveler's Diarrhea Therapeutics Sales by Region (2020-2031)
7.2.2 Asia-Pacific Traveler's Diarrhea Therapeutics Revenue by Region (2020-2031)
7.3 Asia-Pacific Traveler's Diarrhea Therapeutics Sales by Type (2020-2025)
7.4 Asia-Pacific Traveler's Diarrhea Therapeutics Sales by Application (2020-2025)
8 Europe
8.1 Europe Traveler's Diarrhea Therapeutics Market Size YoY Growth 2020-2031
8.2 Europe Traveler's Diarrhea Therapeutics Market Facts & Figures by Country
8.2.1 Europe Traveler's Diarrhea Therapeutics Sales by Country (2020-2031)
8.2.2 Europe Traveler's Diarrhea Therapeutics Revenue by Country (2020-2031)
8.3 Europe Traveler's Diarrhea Therapeutics Sales by Type (2020-2025)
8.4 Europe Traveler's Diarrhea Therapeutics Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Traveler's Diarrhea Therapeutics Market Size YoY Growth 2020-2031
9.2 Latin America Traveler's Diarrhea Therapeutics Market Facts & Figures by Country
9.2.1 Latin America Traveler's Diarrhea Therapeutics Sales by Country (2020-2031)
9.2.2 Latin America Traveler's Diarrhea Therapeutics Revenue by Country (2020-2031)
9.3 Latin America Traveler's Diarrhea Therapeutics Sales by Type (2020-2025)
9.4 Latin America Traveler's Diarrhea Therapeutics Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Traveler's Diarrhea Therapeutics Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Traveler's Diarrhea Therapeutics Market Facts & Figures by Country
10.2.1 Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country (2020-2031)
10.2.2 Middle East and Africa Traveler's Diarrhea Therapeutics Revenue by Country (2020-2031)
10.3 Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Type (2020-2025)
10.4 Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Traveler's Diarrhea Therapeutics Supply Chain Analysis
11.2 Traveler's Diarrhea Therapeutics Key Raw Materials and Upstream Suppliers
11.3 Traveler's Diarrhea Therapeutics Clients Analysis
11.4 Traveler's Diarrhea Therapeutics Sales Channel and Sales Model Analysis
11.4.1 Traveler's Diarrhea Therapeutics Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Traveler's Diarrhea Therapeutics Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Traveler's Diarrhea Therapeutics Distributors
12 Traveler's Diarrhea Therapeutics Market Dynamics
12.1 Traveler's Diarrhea Therapeutics Industry Trends
12.2 Traveler's Diarrhea Therapeutics Market Drivers
12.3 Traveler's Diarrhea Therapeutics Market Challenges
12.4 Traveler's Diarrhea Therapeutics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
 Table 1. Global Traveler's Diarrhea Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Traveler's Diarrhea Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Traveler's Diarrhea Therapeutics Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Traveler's Diarrhea Therapeutics Sales by Region (2020-2025) & (K Units)
 Table 5. Global Traveler's Diarrhea Therapeutics Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Traveler's Diarrhea Therapeutics Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Traveler's Diarrhea Therapeutics Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Traveler's Diarrhea Therapeutics Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Traveler's Diarrhea Therapeutics Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Traveler's Diarrhea Therapeutics Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Traveler's Diarrhea Therapeutics Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Traveler's Diarrhea Therapeutics Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Traveler's Diarrhea Therapeutics Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Traveler's Diarrhea Therapeutics Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Traveler's Diarrhea Therapeutics Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Traveler's Diarrhea Therapeutics Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Traveler's Diarrhea Therapeutics Sales Share by Manufacturer (2020-2025)
 Table 18. Traveler's Diarrhea Therapeutics Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Traveler's Diarrhea Therapeutics Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Traveler's Diarrhea Therapeutics Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Traveler's Diarrhea Therapeutics Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Traveler's Diarrhea Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Traveler's Diarrhea Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Traveler's Diarrhea Therapeutics as of 2024)
 Table 24. Traveler's Diarrhea Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Traveler's Diarrhea Therapeutics Market
 Table 26. Manufacturers Traveler's Diarrhea Therapeutics Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Salix Pharmaceuticals Company Information
 Table 29. Salix Pharmaceuticals Description and Business Overview
 Table 30. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product
 Table 31. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Salix Pharmaceuticals Sales Proportion of Traveler's Diarrhea Therapeutics by Product in 2024
 Table 33. Salix Pharmaceuticals Sales Proportion of Traveler's Diarrhea Therapeutics by Application in 2024
 Table 34. Salix Pharmaceuticals Sales Proportion of Traveler's Diarrhea Therapeutics by Geographic Area in 2024
 Table 35. Salix Pharmaceuticals Recent Developments
 Table 36. P&G Company Information
 Table 37. P&G Description and Business Overview
 Table 38. P&G Traveler's Diarrhea Therapeutics Product
 Table 39. P&G Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. P&G Sales Proportion of Traveler's Diarrhea Therapeutics by Product in 2024
 Table 41. P&G Sales Proportion of Traveler's Diarrhea Therapeutics by Application in 2024
 Table 42. P&G Sales Proportion of Traveler's Diarrhea Therapeutics by Geographic Area in 2024
 Table 43. P&G Recent Developments
 Table 44. Johnson & Johnson Company Information
 Table 45. Johnson & Johnson Description and Business Overview
 Table 46. Johnson & Johnson Traveler's Diarrhea Therapeutics Product
 Table 47. Johnson & Johnson Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. Johnson & Johnson Sales Proportion of Traveler's Diarrhea Therapeutics by Product in 2024
 Table 49. Johnson & Johnson Sales Proportion of Traveler's Diarrhea Therapeutics by Application in 2024
 Table 50. Johnson & Johnson Sales Proportion of Traveler's Diarrhea Therapeutics by Geographic Area in 2024
 Table 51. Johnson & Johnson Recent Developments
 Table 52. Otsuka Pharma Company Information
 Table 53. Otsuka Pharma Description and Business Overview
 Table 54. Otsuka Pharma Traveler's Diarrhea Therapeutics Product
 Table 55. Otsuka Pharma Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Otsuka Pharma Sales Proportion of Traveler's Diarrhea Therapeutics by Product in 2024
 Table 57. Otsuka Pharma Sales Proportion of Traveler's Diarrhea Therapeutics by Application in 2024
 Table 58. Otsuka Pharma Sales Proportion of Traveler's Diarrhea Therapeutics by Geographic Area in 2024
 Table 59. Otsuka Pharma Recent Developments
 Table 60. Valneva Company Information
 Table 61. Valneva Description and Business Overview
 Table 62. Valneva Traveler's Diarrhea Therapeutics Product
 Table 63. Valneva Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Valneva Sales Proportion of Traveler's Diarrhea Therapeutics by Product in 2024
 Table 65. Valneva Sales Proportion of Traveler's Diarrhea Therapeutics by Application in 2024
 Table 66. Valneva Sales Proportion of Traveler's Diarrhea Therapeutics by Geographic Area in 2024
 Table 67. Valneva Recent Developments
 Table 68. Shanghai United Cell Company Information
 Table 69. Shanghai United Cell Description and Business Overview
 Table 70. Shanghai United Cell Traveler's Diarrhea Therapeutics Product
 Table 71. Shanghai United Cell Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Shanghai United Cell Sales Proportion of Traveler's Diarrhea Therapeutics by Product in 2024
 Table 73. Shanghai United Cell Sales Proportion of Traveler's Diarrhea Therapeutics by Application in 2024
 Table 74. Shanghai United Cell Sales Proportion of Traveler's Diarrhea Therapeutics by Geographic Area in 2024
 Table 75. Shanghai United Cell Recent Developments
 Table 76. PaxVax Company Information
 Table 77. PaxVax Description and Business Overview
 Table 78. PaxVax Traveler's Diarrhea Therapeutics Product
 Table 79. PaxVax Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. PaxVax Sales Proportion of Traveler's Diarrhea Therapeutics by Product in 2024
 Table 81. PaxVax Sales Proportion of Traveler's Diarrhea Therapeutics by Application in 2024
 Table 82. PaxVax Sales Proportion of Traveler's Diarrhea Therapeutics by Geographic Area in 2024
 Table 83. PaxVax Recent Developments
 Table 84. Livzon Company Information
 Table 85. Livzon Description and Business Overview
 Table 86. Livzon Traveler's Diarrhea Therapeutics Product
 Table 87. Livzon Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Livzon Sales Proportion of Traveler's Diarrhea Therapeutics by Product in 2024
 Table 89. Livzon Sales Proportion of Traveler's Diarrhea Therapeutics by Application in 2024
 Table 90. Livzon Sales Proportion of Traveler's Diarrhea Therapeutics by Geographic Area in 2024
 Table 91. Livzon Recent Developments
 Table 92. Immuron Company Information
 Table 93. Immuron Description and Business Overview
 Table 94. Immuron Traveler's Diarrhea Therapeutics Product
 Table 95. Immuron Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 96. Immuron Sales Proportion of Traveler's Diarrhea Therapeutics by Product in 2024
 Table 97. Immuron Sales Proportion of Traveler's Diarrhea Therapeutics by Application in 2024
 Table 98. Immuron Sales Proportion of Traveler's Diarrhea Therapeutics by Geographic Area in 2024
 Table 99. Immuron Recent Developments
 Table 100. North America Traveler's Diarrhea Therapeutics Sales by Country (2020-2025) & (K Units)
 Table 101. North America Traveler's Diarrhea Therapeutics Sales by Country (2026-2031) & (K Units)
 Table 102. North America Traveler's Diarrhea Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 103. North America Traveler's Diarrhea Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 104. North America Traveler's Diarrhea Therapeutics Sales by Type (2020-2025) & (K Units)
 Table 105. North America Traveler's Diarrhea Therapeutics Sales by Application (2020-2025) & (K Units)
 Table 106. Asia-Pacific Traveler's Diarrhea Therapeutics Sales by Region (2020-2025) & (K Units)
 Table 107. Asia-Pacific Traveler's Diarrhea Therapeutics Sales by Region (2026-2031) & (K Units)
 Table 108. Asia-Pacific Traveler's Diarrhea Therapeutics Revenue by Region (2020-2025) & (US$ Million)
 Table 109. Asia-Pacific Traveler's Diarrhea Therapeutics Revenue by Region (2026-2031) & (US$ Million)
 Table 110. Asia-Pacific Traveler's Diarrhea Therapeutics Sales by Type (2020-2025) & (K Units)
 Table 111. Asia-Pacific Traveler's Diarrhea Therapeutics Sales by Application (2020-2025) & (K Units)
 Table 112. Europe Traveler's Diarrhea Therapeutics Sales by Country (2020-2025) & (K Units)
 Table 113. Europe Traveler's Diarrhea Therapeutics Sales by Country (2026-2031) & (K Units)
 Table 114. Europe Traveler's Diarrhea Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 115. Europe Traveler's Diarrhea Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 116. Europe Traveler's Diarrhea Therapeutics Sales by Type (2020-2025) & (K Units)
 Table 117. Europe Traveler's Diarrhea Therapeutics Sales by Application (2020-2025) & (K Units)
 Table 118. Latin America Traveler's Diarrhea Therapeutics Sales by Country (2020-2025) & (K Units)
 Table 119. Latin America Traveler's Diarrhea Therapeutics Sales by Country (2026-2031) & (K Units)
 Table 120. Latin America Traveler's Diarrhea Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 121. Latin America Traveler's Diarrhea Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 122. Latin America Traveler's Diarrhea Therapeutics Sales by Type (2020-2025) & (K Units)
 Table 123. Latin America Traveler's Diarrhea Therapeutics Sales by Application (2020-2025) & (K Units)
 Table 124. Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country (2020-2025) & (K Units)
 Table 125. Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country (2026-2031) & (K Units)
 Table 126. Middle East and Africa Traveler's Diarrhea Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 127. Middle East and Africa Traveler's Diarrhea Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 128. Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Type (2020-2025) & (K Units)
 Table 129. Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Application (2020-2025) & (K Units)
 Table 130. Traveler's Diarrhea Therapeutics Key Raw Materials, Industry Status and Trend
 Table 131. Traveler's Diarrhea Therapeutics Key Raw Materials and Upstream Suppliers
 Table 132. Traveler's Diarrhea Therapeutics Clients Status and Trend
 Table 133. Traveler's Diarrhea Therapeutics Typical Clients
 Table 134. Traveler's Diarrhea Therapeutics Distributors
 Table 135. Traveler's Diarrhea Therapeutics Market Trends
 Table 136. Traveler's Diarrhea Therapeutics Market Drivers
 Table 137. Traveler's Diarrhea Therapeutics Market Challenges
 Table 138. Traveler's Diarrhea Therapeutics Market Restraints
 Table 139. Research Programs/Design for This Report
 Table 140. Key Data Information from Secondary Sources
 Table 141. Key Data Information from Primary Sources
 Table 142. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Traveler's Diarrhea Therapeutics Product Picture
 Figure 2. Global Traveler's Diarrhea Therapeutics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2024 & 2031
 Figure 4. Immunization Product Picture
 Figure 5. Non-antibiotic Agents Product Picture
 Figure 6. Antibiotics Product Picture
 Figure 7. Anti-Motility Agents Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Traveler's Diarrhea Therapeutics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 10. Global Traveler's Diarrhea Therapeutics Sales Market Share by Application in 2024 & 2031
 Figure 11. Adult Traveler's Diarrhea
 Figure 12. Children Traveler's Diarrhea
 Figure 13. Traveler's Diarrhea Therapeutics Report Years Considered
 Figure 14. Global Traveler's Diarrhea Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Traveler's Diarrhea Therapeutics Market Size 2020-2031 (US$ Million)
 Figure 16. Global Traveler's Diarrhea Therapeutics Sales 2020-2031 (K Units)
 Figure 17. Global Traveler's Diarrhea Therapeutics Sales Market Share Forecast by Region (2020-2031)
 Figure 18. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Region (2020-2031)
 Figure 19. Global Traveler's Diarrhea Therapeutics Sales Market Share Forecast by Type (2020-2031)
 Figure 20. Global Traveler's Diarrhea Therapeutics Revenue Market Share Forecast by Type (2020-2031)
 Figure 21. Traveler's Diarrhea Therapeutics Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 22. Global Traveler's Diarrhea Therapeutics Sales Market Share Forecast by Application (2020-2031)
 Figure 23. Global Traveler's Diarrhea Therapeutics Revenue Market Share Forecast by Application (2020-2031)
 Figure 24. Traveler's Diarrhea Therapeutics Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 25. Immunization of Traveler's Diarrhea Therapeutics Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Non-antibiotic Agents of Traveler's Diarrhea Therapeutics Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Antibiotics of Traveler's Diarrhea Therapeutics Revenue Market Share by Application, 2024 VS 2031
 Figure 28. Anti-Motility Agents of Traveler's Diarrhea Therapeutics Revenue Market Share by Application, 2024 VS 2031
 Figure 29. Others of Traveler's Diarrhea Therapeutics Revenue Market Share by Application, 2024 VS 2031
 Figure 30. Global Traveler's Diarrhea Therapeutics Sales Share by Manufacturer in 2024
 Figure 31. Traveler's Diarrhea Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 32. Immunization Market Sales Proportion by Manufacturer in 2024
 Figure 33. Non-antibiotic Agents Market Sales Proportion by Manufacturer in 2024
 Figure 34. Antibiotics Market Sales Proportion by Manufacturer in 2024
 Figure 35. Anti-Motility Agents Market Sales Proportion by Manufacturer in 2024
 Figure 36. Others Market Sales Proportion by Manufacturer in 2024
 Figure 37. North America Traveler's Diarrhea Therapeutics Revenue 2020-2031 (US$ Million)
 Figure 38. North America Traveler's Diarrhea Therapeutics Sales Market Share by Type (2020-2025)
 Figure 39. North America Traveler's Diarrhea Therapeutics Sales Market Share by Application (2020-2025)
 Figure 40. Asia-Pacific Traveler's Diarrhea Therapeutics Revenue 2020-2031 (US$ Million)
 Figure 41. Asia-Pacific Traveler's Diarrhea Therapeutics Sales Market Share by Region (2020-2031)
 Figure 42. Asia-Pacific Traveler's Diarrhea Therapeutics Revenue Market Share by Region (2020-2031)
 Figure 43. Asia-Pacific Traveler's Diarrhea Therapeutics Sales Market Share by Type (2020-2025)
 Figure 44. Asia-Pacific Traveler's Diarrhea Therapeutics Sales Market Share by Application (2020-2025)
 Figure 45. Europe Traveler's Diarrhea Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 46. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Country (2020-2031)
 Figure 47. Europe Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 48. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Type (2020-2025)
 Figure 49. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Application (2020-2025)
 Figure 50. Latin America Traveler's Diarrhea Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 51. Latin America Traveler's Diarrhea Therapeutics Sales Market Share by Country (2020-2031)
 Figure 52. Latin America Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2020-2025)
 Figure 53. Latin America Traveler's Diarrhea Therapeutics Sales Market Share by Type (2020-2025)
 Figure 54. Latin America Traveler's Diarrhea Therapeutics Sales Market Share by Application (2020-2025)
 Figure 55. Middle East and Africa Traveler's Diarrhea Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 56. Middle East and Africa Traveler's Diarrhea Therapeutics Sales Market Share by Country (2020-2031)
 Figure 57. Middle East and Africa Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 58. Middle East and Africa Traveler's Diarrhea Therapeutics Sales Market Share by Type (2020-2025)
 Figure 59. Middle East and Africa Traveler's Diarrhea Therapeutics Sales Market Share by Application (2020-2025)
 Figure 60. Traveler's Diarrhea Therapeutics Supply Chain (Upstream and Downstream Market)
 Figure 61. Global Production Market Share of Traveler's Diarrhea Therapeutics Raw Materials by Region in 2024
 Figure 62. Traveler's Diarrhea Therapeutics Distribution Channels
 Figure 63. Global Traveler's Diarrhea Therapeutics Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 64. Global Traveler's Diarrhea Therapeutics Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners